Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
446.80
+12.80 (2.95%)
At close: Aug 18, 2025, 4:00 PM HKT

HKG:6990 Revenue

Sichuan Kelun-Biotech Biopharmaceutical had revenue of 550.25M CNY in the half year ending December 31, 2024, with 19.90% growth. This brings the company's revenue in the last twelve months to 1.50B, down -20.05% year-over-year. In the year 2024, Sichuan Kelun-Biotech Biopharmaceutical had annual revenue of 1.93B with 25.48% growth.

Revenue (ttm)
1.50B CNY
Revenue Growth
-20.05%
P/S Ratio
62.10
Revenue / Employee
816.93K CNY
Employees
1,837
Market Cap
102.11B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.93B392.55M25.48%
Dec 31, 20231.54B736.56M91.62%
Dec 31, 2022803.93M771.61M2,387.26%
Dec 31, 202132.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition